EDITORIAL
Published on 31 Mar 2020
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
doi 10.3389/fimmu.2020.00507
- 2,427 views
- 5 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
24k
Total downloads
79k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 17 Feb 2020
Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
doi 10.3389/fimmu.2020.00122
- 6,071 views
- 46 citations
REVIEW
Published on 10 Dec 2019
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
doi 10.3389/fimmu.2019.02876
- 10,545 views
- 73 citations
ORIGINAL RESEARCH
Published on 08 Nov 2019
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation
doi 10.3389/fimmu.2019.02614
- 4,528 views
- 35 citations
REVIEW
Published on 29 Oct 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
doi 10.3389/fimmu.2019.02393
- 17,897 views
- 111 citations
ORIGINAL RESEARCH
Published on 09 Oct 2019
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
doi 10.3389/fimmu.2019.02353
- 6,071 views
- 29 citations
REVIEW
Published on 02 Oct 2019
CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
doi 10.3389/fimmu.2019.02216
- 5,352 views
- 24 citations
MINI REVIEW
Published on 25 Sep 2019
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
doi 10.3389/fimmu.2019.02303
- 3,998 views
- 16 citations
ORIGINAL RESEARCH
Published on 14 Aug 2019
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
doi 10.3389/fimmu.2019.01939
- 7,472 views
- 41 citations
ORIGINAL RESEARCH
Published on 21 May 2019
Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
doi 10.3389/fimmu.2019.01079
- 2,602 views
- 9 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Molecular Innate Immunity
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 79kTopic views
- 53kArticle views
- 24kArticle downloads